MedPath

Analgesic Efficacy of Ultrasound-guided Transverse-abdominal Plain Blockade in Urological Surgery

Phase 4
Completed
Conditions
Postoperative Pain
Interventions
Procedure: Postoperative transverse abdominal plain (TAP) blockade
Registration Number
NCT01501565
Lead Sponsor
Fundacio Puigvert
Brief Summary

The purpose of this study is to compare pain level (according to numerical score)at 4, 8, 12 and 24 postoperative hours between patients under transverse abdominal plain blockade (TAP) and patients under conventional analgesia. Also the opioid consumption is assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
141
Inclusion Criteria
  • > 18 yrs.
  • Patients undergo laparoscopic urologic surgery
  • Physical status ASA < 3
  • Surgical procedure without complications
  • Signed informed consent
Exclusion Criteria
  • Allergy to bupivacaine chlorhydrate
  • Patients with chronic pain treatment
  • Alcoholism
  • Decompensated hepatic disease
  • Coagulation disorders
  • BMI > 35
  • Patient involved in another clinical trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
TAPPostoperative transverse abdominal plain (TAP) blockadeTransverse abdominal plain (TAP) blockade with local anesthetic: Bupivacaine chlorhydrate 0.25% adjusted by weight and type of surgery. Maximum dose: 150 mg of bupivacaine. Two approaches are done: 1)Posterior TAP: the needle insertion point is cephalad to the iliac crest, behind the midaxillary line. The needle is inserted under ultrasound guidance in plane. Local anesthetics is deposited between the internal oblique and transversus abdominis muscles, 2)Subcostal TAP: the needle is inserted ultrasound guided perpendicularly to abdominal wall, directed parallel to the costal margin but oblique to the sagittal plane. Local anesthestic is deposited between transversus abdominis and the rectus abdominis muscles.
Primary Outcome Measures
NameTimeMethod
Pain levelChange in pain from admittance to 24 hours postoperatively

Pain is assessed by numerical scale (0 to 10) where 0 is no pain and 10 is the most intense pain possible. Pain will be assessed at 4, 6 , 8, 12 and 24 hours.

Secondary Outcome Measures
NameTimeMethod
Analgesic consumption as a rescue therapywithin 24 postoperative hours

Analgesic consumption: morphine in miligrams.

Incidence of postoperative nausea and vomiting (PONV) related to therapywithin 24 postoperative hours

Assessment of PONV incidence and antiemetic drugs consumption.

Incidence of urethral/bladder spasmwithin 24 postoperative hours

Pain due to bladder catheter.

Assessment of oral intake tolerancewithin 24 postoperative hours

Assessment at 6 postoperative hours for liquids, and solid food at 24 postoperative hours.

Patient satisfactionwithin 24 postoperative hours

Assessed by ordinal scale: Very pleased/Pleased/little pleased/little unpleased/unpleased/very unpleased

Trial Locations

Locations (1)

Fundació Puigvert

🇪🇸

Barcelona, Spain

© Copyright 2025. All Rights Reserved by MedPath